Biotechnology is an economic sector in which you can’t take a single step without encountering a veritable thicket of regulations at the domestic, European, and global levels.

Recent investments, public as well as private, in biotechnology – a unique field combining science, new technologies, and business – have been leading to its dynamic growth and to spectacular commercialisation of scientific achievements. Yet the uniqueness of this field is also accounted for by its complexity from the regulatory perspective [...]

 

The full text of this article is available (in Polish) in Dziennik Gazeta Prawna. If you are interested in an English-language version or in discussing the issues raised herein with one of our lawyers, please contact: kontakt@gessel.pl